» Articles » PMID: 34518525

Contact Tracing is an Imperfect Tool for Controlling COVID-19 Transmission and Relies on Population Adherence

Overview
Journal Nat Commun
Specialty Biology
Date 2021 Sep 14
PMID 34518525
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Emerging evidence suggests that contact tracing has had limited success in the UK in reducing the R number across the COVID-19 pandemic. We investigate potential pitfalls and areas for improvement by extending an existing branching process contact tracing model, adding diagnostic testing and refining parameter estimates. Our results demonstrate that reporting and adherence are the most important predictors of programme impact but tracing coverage and speed plus diagnostic sensitivity also play an important role. We conclude that well-implemented contact tracing could bring small but potentially important benefits to controlling and preventing outbreaks, providing up to a 15% reduction in R. We reaffirm that contact tracing is not currently appropriate as the sole control measure.

Citing Articles

A Retrospective Analysis of Jordan's National COVID-19 Call Center: Operations, Effectiveness, and Lessons Learned.

Alrawashdeh A, Simmons N, Alhawarat M, Maayeh M, Kheirallah K J Multidiscip Healthc. 2024; 17:5079-5089.

PMID: 39534874 PMC: 11556226. DOI: 10.2147/JMDH.S475335.


A systematic literature review on public health and healthcare resources for pandemic preparedness planning.

Beishuizen B, Stein M, Buis J, Tostmann A, Green C, Duggan J BMC Public Health. 2024; 24(1):3114.

PMID: 39529010 PMC: 11552315. DOI: 10.1186/s12889-024-20629-z.


Identifying Barriers to the Adoption of Digital Contact Tracing Apps in England: Semistructured Interview Study With Professionals Involved in the Pandemic Response.

Palmer A, Sharma S, Nagpal J, Kimani V, Mai F, Ahmed Z JMIR Form Res. 2024; 8:e56000.

PMID: 39133910 PMC: 11347901. DOI: 10.2196/56000.


A mathematical model to assess the effectiveness of test-trace-isolate-and-quarantine under limited capacities.

Heidecke J, Fuhrmann J, Barbarossa M PLoS One. 2024; 19(3):e0299880.

PMID: 38470895 PMC: 10931449. DOI: 10.1371/journal.pone.0299880.


Non-pharmaceutical interventions to reduce COVID-19 transmission in the UK: a rapid mapping review and interactive evidence gap map.

Duval D, Evans B, Sanders A, Hill J, Simbo A, Kavoi T J Public Health (Oxf). 2024; 46(2):e279-e293.

PMID: 38426578 PMC: 11141784. DOI: 10.1093/pubmed/fdae025.


References
1.
Ganyani T, Kremer C, Chen D, Torneri A, Faes C, Wallinga J . Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Euro Surveill. 2020; 25(17). PMC: 7201952. DOI: 10.2807/1560-7917.ES.2020.25.17.2000257. View

2.
Zitek T . The Appropriate Use of Testing for COVID-19. West J Emerg Med. 2020; 21(3):470-472. PMC: 7234686. DOI: 10.5811/westjem.2020.4.47370. View

3.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

4.
Keeling M, Hollingsworth T, Read J . Efficacy of contact tracing for the containment of the 2019 novel coronavirus (COVID-19). J Epidemiol Community Health. 2020; 74(10):861-866. PMC: 7307459. DOI: 10.1136/jech-2020-214051. View

5.
van Kasteren P, van der Veer B, van den Brink S, Wijsman L, de Jonge J, van den Brandt A . Comparison of seven commercial RT-PCR diagnostic kits for COVID-19. J Clin Virol. 2020; 128:104412. PMC: 7206434. DOI: 10.1016/j.jcv.2020.104412. View